Condition

Femoropopliteal Stenosis clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Femoropopliteal Stenosis clinical trials that are recruiting, at sites in 4 countries (most in France (1), Austria (1), Australia (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Femoropopliteal Stenosis clinical trials

StudyPhaseWhereStatusRegistered
Using AI to analyze the superficial femoral artery for better treatment of artery disease — Strasbourg, Bas-Rhin Recruiting Feb 15, 2024
Comparing two types of venous bypass for leg artery issues — Salzburg Recruiting Oct 13, 2023
Treatment for patients with blocked femoropopliteal arteries using a new vascular scaffold — Sydney, New South Wales and 7 other locations Recruiting Oct 14, 2020

All recruiting trials (3)

Related topics

Claudication, IntermittentCritical Limb-Threatening IschemiaPeripheral Arterial DiseasePeripheral Arterial Occlusive DiseasePeripheral Artery DiseaseStenosisVascular Diseases

Quick answers

How many Femoropopliteal Stenosis clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in France (1 trial), Austria (1 trial), Australia (1 trial), New Zealand (1 trial). Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.